Peer-influenced content. Sources you trust. No registration required. This is HCN.

Articles related to CHECKPOINT INHIBITORS

Clinical Oncology News

Acetaminophen May Worsen Response to Immunotherapy in Cancer Patients

Oncology, Medical August 15th 2022

Oncology News Central (ONC)

Toxicity From Sotorasib-Immunotherapy Combo Leads to New Approach

Oncology, Medical August 15th 2022

Clinical Advances in Hematology & Oncology

JAK Inhibitors in the Treatment of Myelofibrosis

Hematology/Oncology August 8th 2022

Journal of Clinical Oncology

Fuzuloparib Maintenance Therapy in Patients with Platinum-Sensitive, Recurrent Ovarian Carcinoma (FZOCUS-2): A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase III Trial

Oncology, Medical August 2nd 2022

MedPage Today

Chemo-Free Maintenance Combo Promising in Pancreatic Cancer

Oncology, Medical July 25th 2022

Medical Professionals Reference (MPR)

FDA Warns of Increased Side Effects, Death Risk with Duvelisib

Hematology/Oncology July 5th 2022

The Healthcare Communications Network is owned and operated by IQVIA Inc.

Click below to leave this site and continue to IQVIA’s Privacy Choices form